These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33942650)

  • 1. Designing a Graphic Novel: Engaging Community, Arts, and Culture Into Public Health Initiatives.
    Febres-Cordero S; Sherman ADF; Karg J; Kelly U; Thompson LM; Smith K
    Health Promot Pract; 2021 May; 22(1_suppl):35S-43S. PubMed ID: 33942650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing Fear of Negative Consequences of Overdose Response: A Qualitative Study of the Perceptions of Service Industry Workers Who Encounter an Opioid Overdose in an Urban Commercial District in Atlanta, Georgia.
    Febres-Cordero S; Thompson LM; Chalfant OS; Sherman ADF; Winiker AK; Kelly UA; Smith KM
    Workplace Health Saf; 2024 Jun; 72(6):244-252. PubMed ID: 38243156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It's what the community demands: Results of community-based emergency opioid overdose trainings.
    Febres-Cordero S; Smith DJ; Wulkan AZ; Béliveau AJ; Gish A; Zine S; Fugitt L; Giordano NA
    Public Health Nurs; 2023 Jan; 40(1):44-53. PubMed ID: 36377302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.
    Young S; Williams S; Otterstatter M; Lee J; Buxton J
    BMJ Open; 2019 Oct; 9(10):e030046. PubMed ID: 31662368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
    Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I
    Drug Alcohol Rev; 2018 May; 37(4):464-471. PubMed ID: 27071354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.
    Wolfe S; Bouffard DL; Modesto-Lowe V
    Conn Med; 2016; 80(6):325-34. PubMed ID: 27509638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study.
    Siegler A; Huxley-Reicher Z; Maldjian L; Jordan R; Oliver C; Jakubowski A; Kunins HV
    Drug Alcohol Depend; 2017 Oct; 179():124-130. PubMed ID: 28772172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students.
    Berland N; Fox A; Tofighi B; Hanley K
    Subst Abus; 2017; 38(2):123-128. PubMed ID: 28027016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stayin' Alive in Little 5: Application of Sentiment Analysis to Investigate Emotions of Service Industry Workers Responding to Drug Overdoses.
    Febres-Cordero S; Smith DJ
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operation Naloxone: Overdose prevention service learning for student pharmacists.
    Hill LG; Sanchez JP; Laguado SA; Lawson KA
    Curr Pharm Teach Learn; 2018 Oct; 10(10):1348-1353. PubMed ID: 30527364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
    Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
    Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.
    Takeda MY; Katzman JG; Dole E; Bennett MH; Alchbli A; Duhigg D; Yonas H
    Subst Abus; 2016; 37(4):591-596. PubMed ID: 27093555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.